Naibedya Chattopadhyay
Overview
Explore the profile of Naibedya Chattopadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
2367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma S, Kumar S, Tomar M, Chauhan D, Sadhukhan S, Kulkarni C, et al.
Endocrine
. 2025 Feb;
PMID: 39918636
Introduction: Hyperphosphatemia leads to abnormal mineralization of bones and soft tissues in patients with chronic kidney disease-induced secondary hyperparathyroidism (CKD-SHPT). Sevelamer lowers phosphate levels by binding to dietary phosphate in...
2.
Saha S, Mittal M, Goswami R, Narang P, Balhara Y, Chattopadhyay N
Cureus
. 2024 Dec;
16(11):e73643.
PMID: 39677152
Background: Disulfiram is widely used to treat alcohol use disorder. Alcohol per se adversely affects bone health. In the experimental study, disulfiram leads to apoptosis of osteoblast and significant osteopenia...
3.
Tufail E, Sanyal S, Mithal A, Sanyal S, Chattopadhyay N
J Endocrinol
. 2024 Dec;
264(2.
PMID: 39656031
Various metabolic abnormalities, including obesity, insulin resistance, hypertension, dyslipidemia, hyperthyroidism and low vitamin D levels, have been linked to both osteopenia and sarcopenia. Osteosarcopenia is also commonly observed in older...
4.
Mehta P, Sharma A, Goswami A, Gupta S, Singhal V, Srivastava K, et al.
Front Endocrinol (Lausanne)
. 2024 Nov;
15:1475446.
PMID: 39525853
Background: Genetic mutations have been reported in a number of bone disorders with or without extra-skeletal manifestations. The purpose of the present study was to investigate the genetic cause in...
5.
Mehta P, Vishvkarma R, Gupta S, Chattopadhyay N, Rajender S
Mol Biol Rep
. 2024 Nov;
51(1):1117.
PMID: 39495367
No abstract available.
6.
Chakravarti B, Rajput S, Srivastava A, Sharma L, Sinha R, Chattopadhyay N, et al.
Phytother Res
. 2024 Oct;
38(12):6062-6081.
PMID: 39480044
Female hormone-dependent cancers depend on estrogen for their growth. Numerous studies have explored the antitumor effect of dietary isoflavones on female hormone-dependent cancers. Still, few clinical evidence supports the use...
7.
Shah A, Chand D, Ahamad S, Porwal K, Chourasia M, Mohanan K, et al.
Biochem Pharmacol
. 2024 Oct;
230(Pt 2):116587.
PMID: 39447984
Wnt signaling is one of the key regulators of bone development and homeostasis. Wnt signaling regulates key biological events, including stem cell fate and osteoblast and osteoclast activity, leading to...
8.
Sapra L, Saini C, Sharma S, Nanda D, Nilakhe A, Chattopadhyay N, et al.
JBMR Plus
. 2024 Oct;
8(11):ziae120.
PMID: 39399159
Recent discoveries have established the pivotal role of IL-9-secreting immune cells in a wide spectrum of inflammatory and autoimmune diseases. However, little is known about how IL-9 contributes to the...
9.
Sharma S, Shankar V, Rajender S, Mithal A, Rao S, Chattopadhyay N
Front Endocrinol (Lausanne)
. 2024 Sep;
15:1426490.
PMID: 39257899
Background And Aims: Reduced bone mineral density (BMD) and microarchitectural deterioration contribute to increased fracture risk. Although the effects of anti-fracture medications (AFMs) on BMD are well-documented, their impact on...
10.
Rajput S, Kulkarni C, Sharma S, Tomar M, Khatoon S, Gupta A, et al.
Arch Pharm Res
. 2024 Jul;
47(8-9):736-755.
PMID: 39073743
Adiponectin, an adipokine, regulates metabolic processes, including glucose flux, lipid breakdown, and insulin response, by activating adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2). We have previously shown that globular...